With digital therapeutics' trailblazers in jeopardy, experts think more failures are on the horizon. Covering digital therapeutics hasn't been easyInsurers, the ultimate gatekeepers in healthcare, have been slow to warm to the idea of reimbursing prescription digital therapeutics. Plus, most digital therapeutics don't integrate with electronic-health-records systems, making it difficult for clinicians to track their patients' progress. Senators reintroduced a bill in March that would guarantee Medicare reimbursement for prescription digital therapeutics. Want to tell us about your experience with digital therapeutics?

---

Persons: Pear, It's, Akili, Jeffrey Abraham, Rick Bartels, Bartels, Corey McCann, Matt Stoudt, Stoudt, Matthew Stoudt, keener, we'll, that's, Abraham, Rebecca Torrence Organizations: Morning, Pear Therapeutics, Food and Drug Administration, FDA, Digital Therapeutics, Pear, Centers, Medicare, Services, Senators, CMS